{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T11:17:23Z","timestamp":1720783043323},"reference-count":6,"publisher":"BMJ","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.p1631","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T13:50:12Z","timestamp":1689342612000},"page":"p1631","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["FDA approves daily over-the-counter oral contraceptive with no age restrictions"],"prefix":"10.1136","author":[{"given":"Janice Hopkins","family":"Tanne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"2023071410500817000_382.jul14_11.p1631.1","unstructured":"Food and Drug Administration. FDA approves first nonprescription daily oral contraceptive. 13 Jul 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-nonprescription-daily-oral-contraceptive"},{"key":"2023071410500817000_382.jul14_11.p1631.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p1463"},{"key":"2023071410500817000_382.jul14_11.p1631.3","unstructured":"Food and Drug Administration. Opill (0.075 mg oral norgestrel tablet) information. Updated 13 Jul 2023. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/opill-0075mg-oral-norgestrel-tablet-information?utm_medium=e"},{"key":"2023071410500817000_382.jul14_11.p1631.4","unstructured":"US Department of Health and Human Services. Statement by HHS secretary Becerra on FDA approval of first daily over-the-counter oral contraceptive. 13 Jul 2023. https:\/\/www.hhs.gov\/about\/news\/2023\/07\/13\/statement-hhs-secretary-becerra-fda-approval-first-daily-over-counter-oral-contraceptive.html"},{"key":"2023071410500817000_382.jul14_11.p1631.5","unstructured":"Long M, Frederiksen B, Ranji U, et al. Interest in using over-the-counter oral contraceptive pills: findings from the 2022 KFF women\u2019s health survey. 3 Nov 2022. https:\/\/www.kff.org\/womens-health-policy\/issue-brief\/interest-using-over-the-counter-oral-contraceptive-pills-findings-2022-kff-womens-health-survey\/"},{"key":"2023071410500817000_382.jul14_11.p1631.6","unstructured":"American College of Obstetricians and Gynecologists. ACOG praises FDA approval of over-the-counter access to birth control pill. 13 Jul 2023. https:\/\/www.acog.org\/news\/news-releases\/2023\/07\/acog-praises-fda-approval-of-over-the-counter-access-to-birth-control-pill"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.p1631","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.p1631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T17:50:18Z","timestamp":1689357018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.p1631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":6,"alternative-id":["10.1136\/bmj.p1631"],"URL":"https:\/\/doi.org\/10.1136\/bmj.p1631","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}